Paula Green net worth and biography

Paula Green Biography and Net Worth

Paula Green is an experienced human resources executive with a track record of developing and delivering high-impact people strategies, solutions, processes and tools that support leadership competencies to empower a high performing organization. Prior to Twist Bioscience, she served as Vice President, Head of Human Resources at QIAGEN, where she oversaw 50 human resources professionals supporting 4,000 employees through mergers and acquisitions, restructurings and other pivotal corporate transactions. She was the human resources manager for Operon Technologies (acquired by QIAGEN) where her responsibilities included creating strategy, overseeing benefits for all employees, and delivering training, recruitment and retention programs.  She also worked as a Human Resources Consultant for the Federal Home Loan Bank of San Francisco. Paula holds a BS in Organizational Behavior from the University of San Francisco.

What is Paula Green's net worth?

The estimated net worth of Paula Green is at least $339,072.12 as of September 16th, 2022. Ms. Green owns 14,199 shares of Twist Bioscience stock worth more than $339,072 as of February 6th. This net worth evaluation does not reflect any other assets that Ms. Green may own. Learn More about Paula Green's net worth.

How do I contact Paula Green?

The corporate mailing address for Ms. Green and other Twist Bioscience executives is 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA, 94080. Twist Bioscience can also be reached via phone at (800) 719-0671 and via email at [email protected] Learn More on Paula Green's contact information.

Has Paula Green been buying or selling shares of Twist Bioscience?

Paula Green has not been actively trading shares of Twist Bioscience within the last three months. Most recently, Paula Green sold 8,514 shares of the business's stock in a transaction on Friday, September 16th. The shares were sold at an average price of $37.43, for a transaction totalling $318,679.02. Following the completion of the sale, the senior vice president now directly owns 14,199 shares of the company's stock, valued at $531,468.57. Learn More on Paula Green's trading history.

Who are Twist Bioscience's active insiders?

Twist Bioscience's insider roster includes William Banyai (Insider), Robert Chess (Director), Keith Crandell (Director), Mark Daniels (Insider), Patrick Finn (Insider), Paula Green (SVP), Jan Johannessen (Director), Emily Leproust (CEO), James Thorburn (CFO), and Patrick Weiss (COO). Learn More on Twist Bioscience's active insiders.

Are insiders buying or selling shares of Twist Bioscience?

In the last year, Twist Bioscience insiders bought shares 1 times. They purchased a total of 8,550 shares worth more than $250,087.50. In the last year, insiders at the sold shares 17 times. They sold a total of 60,304 shares worth more than $2,563,263.15. The most recent insider tranaction occured on October, 25th when insider William Banyai sold 379 shares worth more than $11,199.45. Insiders at Twist Bioscience own 11.8% of the company. Learn More about insider trades at Twist Bioscience.

Information on this page was last updated on 10/25/2022.

Paula Green Insider Trading History at Twist Bioscience

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/16/2022Sell8,514$37.43$318,679.0214,199View SEC Filing Icon  
6/15/2022Sell10,067$30.47$306,741.4914,727View SEC Filing Icon  
6/14/2021Sell14,161$113.84$1,612,088.2420,095View SEC Filing Icon  
5/21/2021Sell490$98.64$48,333.6020,885View SEC Filing Icon  
4/26/2021Sell264$135.60$35,798.4021,409View SEC Filing Icon  
1/25/2021Sell246$193.00$47,478.0022,496View SEC Filing Icon  
12/15/2020Sell4,634$139.73$647,508.8222,804View SEC Filing Icon  
9/16/2020Sell26,988$63.37$1,710,229.5646,458View SEC Filing Icon  
6/15/2020Sell16,833$38.00$639,654.0039,448View SEC Filing Icon  
See Full Table

Paula Green Buying and Selling Activity at Twist Bioscience

This chart shows Paula Green's buying and selling at Twist Bioscience by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Twist Bioscience Company Overview

Twist Bioscience logo
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. Its products include genes, oligo pools, Next Generation Sequencing (NGS), variant libraries, synthetic controls, antibody discovery, and SARS-CoV-2 Tools. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment consists of Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck on February 4, 2013 and is headquartered in San Francisco, CA.
Read More

Today's Range

Now: $23.73
Low: $23.38
High: $25.93

50 Day Range

MA: $25.93
Low: $21.92
High: $30.90

2 Week Range

Now: $23.73
Low: $21.78
High: $66.15

Volume

1,860,732 shs

Average Volume

1,114,649 shs

Market Capitalization

$1.34 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Get the Name & Ticker Here